Vistide (Cidofovir) Important Safety Information from Gilead Sciences International Limited as approved by the Irish Medicines Board
05 March 2013
Important Safety Information communication from Gilead Sciences International Limited on product recall leading to a shortage in commercial supply in the EU affecting Vistide (Cidofovir) 75 mg/ml concentrate for solution for infusion.
Important Safety Information - Vistide (Cidofovir) 75 mg/ml concentrate for solution for infusion